Biogaia AB
STO:BIOG B

Watchlist Manager
Biogaia AB Logo
Biogaia AB
STO:BIOG B
Watchlist
Price: 110.2 SEK 0.64% Market Closed
Market Cap: 11.1B SEK
Have any thoughts about
Biogaia AB?
Write Note

Biogaia AB
Deferred Income Tax

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Biogaia AB
Deferred Income Tax Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Deferred Income Tax CAGR 3Y CAGR 5Y CAGR 10Y
Biogaia AB
STO:BIOG B
Deferred Income Tax
kr15.2m
CAGR 3-Years
10%
CAGR 5-Years
18%
CAGR 10-Years
N/A
Bonesupport Holding AB
STO:BONEX
Deferred Income Tax
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Vitrolife AB
STO:VITR
Deferred Income Tax
kr1B
CAGR 3-Years
317%
CAGR 5-Years
107%
CAGR 10-Years
51%
Probi AB
STO:PROB
Deferred Income Tax
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Swedish Orphan Biovitrum AB (publ)
STO:SOBI
Deferred Income Tax
kr6.5B
CAGR 3-Years
24%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
BioArctic AB
STO:BIOA B
Deferred Income Tax
kr12.4m
CAGR 3-Years
-16%
CAGR 5-Years
-18%
CAGR 10-Years
N/A
No Stocks Found

Biogaia AB
Glance View

Market Cap
11.1B SEK
Industry
Biotechnology

BioGaia AB engages in the development, marketing, and sale of probiotic products. The company is headquartered in Stockholm, Stockholm. The firm develops, markets and sells probiotic products with documented health benefits. The products are primarily based on different strains of the lactic acid bacterium Limosilactobacillus reuteri. The Company’s activities are divided into three segments: The Paediatrics segment drops, gut health tablets, oral rehydration solution (ORS) and cultures to be used as ingredients in licensee products; The Adult Health segment (gut health tablets, oral health lozenges and cultures as an ingredient in a licensee’s dairy products) and the Other (royalties in respect of development projects, revenue from packaging solutions in the subsidiary CapAble, etc.). The firm operates worldwide.

BIOG B Intrinsic Value
112.88 SEK
Undervaluation 2%
Intrinsic Value
Price

See Also

What is Biogaia AB's Deferred Income Tax?
Deferred Income Tax
15.2m SEK

Based on the financial report for Dec 31, 2023, Biogaia AB's Deferred Income Tax amounts to 15.2m SEK.

What is Biogaia AB's Deferred Income Tax growth rate?
Deferred Income Tax CAGR 5Y
18%

Over the last year, the Deferred Income Tax growth was 21%. The average annual Deferred Income Tax growth rates for Biogaia AB have been 10% over the past three years , 18% over the past five years .

Back to Top